Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Journal of the European Academy of Dermatology and Venereology : JEADV|July 16, 2013
Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm RegistryJ M Carrascosa, M Vilavella, I Garcia-Doval, et al.
The Australasian Journal of Dermatology|July 12, 2023
Effectiveness and safety of brodalumab in the treatment of plaque, scalp and palmoplantar psoriasis: A multicentre retrospective study in a Spanish populationA Sahuquillo-Torralba, M Hospital-Gil, E Vilarrasa-Rull, et al.
Actas Dermo-Sifiliograficas|September 24, 2016
Management of Biologic Therapy in Moderate to Severe Psoriasis in Surgical Patients: Data From the Spanish Biobadaderm RegistryS Galiano Mejías, G Carretero, C Ferrandiz, et al.
Experimental Dermatology|July 31, 2024
Genetic polymorphisms to identify patients with an optimal response to tildrakizumab in psoriasis patients from real-life clinical practiceB Butrón-Bris, M Llamas-Velasco, M C Ovejero-Benito, et al.
Actas Dermo-Sifiliograficas|September 11, 2013
Spanish evidence-based guidelines on the treatment of psoriasis with biologic agents, 2013. Part 1: on efficacy and choice of treatment. Spanish Psoriasis Group of the Spanish Academy of Dermatology and VenereologyL Puig, J M Carrascosa, G Carretero, et al.
Actas Dermo-Sifiliograficas|June 12, 2018
Description of Patients Treated with Biologic Drugs as First-Line Systemic Therapy in the BIOBADADERM Registry Between 2008 and 2016G Carretero Hernández, C Ferrándiz, R Rivera Díaz, et al.
Actas Dermo-Sifiliograficas|October 15, 2020
Changing Trends in Drug Prescription and Causes of Treatment Discontinuation of First Biologic Over Ten Years in Psoriasis in the Spanish Biobadaderm RegistryD P Ruiz-Genao, G Carretero, R Rivera, et al.
Actas Dermo-Sifiliograficas|April 16, 2022
Moderate to Severe Psoriasis in Pediatric and Young Patients: The BIOBADADERM Registry ExperienceL M Nieto Benito, G Carretero, R Rivera-Díaz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 28, 2023
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practiceE Muñoz-Aceituno, B Butrón-Bris, M C Ovejero-Benito, et al.
Actas Dermo-Sifiliograficas|March 7, 2024
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.
Pageof 10